Health Technology Assessment

Barriers to generalizability of health economic evaluations in Latin America and the Caribbean region

Augustovski F, Iglesias C, Manca A, Drummond M, Rubinstein A, Marti SG. Barriers to generalizability of health economic evaluations in Latin America and the Caribbean region. Pharmacoeconomics. 2009;27(11):919-929.

Barriers to generalizability of health economic evaluations in Latin America and the Caribbean region See more "

Good research practices for measuring drug costs in cost-effectiveness analyses: an international perspective: the ISPOR Drug Cost Task Force report–Part VI

LZ Shi,M. Hodges,M. Drummond, J. Ahn,SC Li,SL Hu,F. Augustovski, JW Hay and J. Smeeding. Good Research Practices for Measuring Drug Costs in Cost-Effectiveness Analyzes: An International Perspective: The ISPOR Drug Cost Task Force Report-Part VI. Value in Health. 2010;13(1):10.1111/j.1524-4733.2009.00662.x.

Good research practices for measuring drug costs in cost-effectiveness analyses: an international perspective: the ISPOR Drug Cost Task Force report–Part VI See more "

Development and implementation of health technology assessment in Argentina: two steps forward and one step back

Rubinstein A, Pichon-Riviere A, Augustovski F. Development and implementation of health technology assessment in Argentina: two steps forward and one step back. Int J Technol Assess Health Care. 2009;25 Suppl 1:260-269.

Development and implementation of health technology assessment in Argentina: two steps forward and one step back See more "

Generalized cost-effectiveness analysis of a package of interventions to reduce cardiovascular disease in Buenos Aires, Argentina

Rubinstein A, Garcia Marti S, Souto A, Ferrante D, Augustovski F. Generalized cost-effectiveness analysis of a package of interventions to reduce cardiovascular disease in Buenos Aires, Argentina. Cost Eff Resour Alloc. 2009;7:10.

Generalized cost-effectiveness analysis of a package of interventions to reduce cardiovascular disease in Buenos Aires, Argentina See more "

Cost-effectiveness analysis of entecavir versus lamivudine in patients with chronic hepatitis B

Calcagno JI, Augustovski F, Gadano A, Souto A, Yuan Y. [Cost-effectiveness analysis of entecavir versus lamivudine in patients with chronic hepatitis B]. Acta Gastroenterol Latinoam. 2008;38(4):260-273.

Cost-effectiveness analysis of entecavir versus lamivudine in patients with chronic hepatitis B See more "

Supporting the delivery of cost-effective interventions in primary health-care systems in low-income and middle-income countries: an overview of systematic reviews

Lewin S, Lavis JN, Oxman AD, et al. Supporting the delivery of cost-effective interventions in primary health-care systems in low-income and middle-income countries: an overview of systematic reviews. Lancet. 2008;372(9642):928-939.

Supporting the delivery of cost-effective interventions in primary health-care systems in low-income and middle-income countries: an overview of systematic reviews See more "

The Argentine-Spanish SF-36 Health Survey was successfully validated for local outcome research

Augustovski FA, Lewin G, García-Elorrio E, Rubinstein A. The Argentine-Spanish SF-36 Health Survey was successfully validated for local outcome research. J Clin Epidemiol. 2008 Dec;61(12):1279-1284.e6. doi: 10.1016/j.jclinepi.2008.05.004. Epub 2008 Sep 10. PMID: 18786809.

The Argentine-Spanish SF-36 Health Survey was successfully validated for local outcome research See more "